Profile
Sarah Connors worked as a Media Contact at AMAG Pharmaceuticals, Inc. and as a Vice President-Corporate Communications at Karyopharm Therapeutics, Inc.
Former positions of Sarah Connors
| Companies | Position | End |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Public Communications Contact | 01/03/2023 |
| AMAG PHARMACEUTICALS, INC. | Public Communications Contact | 01/06/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sarah Connors
